Transposagen Biopharmaceuticals, Inc. Announces New Product Offering: TGEM(TM) Genetically Modified Rat Models
Published: Apr 22, 2010
LEXINGTON, Ky., April 22 /PRNewswire/ -- Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand. A complete list of genetically modified and knockout rat models being offered by Transposagen is listed on their website – www.transposagenbio.com.